Preventive therapy for migraine headache includes identification of migrain
e precipitants, possible adjustments in lifestyle, appropriate management o
f acute headache, and, when necessary, the use of pharmacologic agents. The
re are no well-controlled clinical trials with sufficient patient numbers t
o support the use of any agent in the prevention of migraine headache in ch
ildren. Data on the use of amitriptyline and divalproex sodium in open-labe
l studies suggest that these agents may be efficacious. The mechanism of ac
tion for these agents is unknown but may be related to the 5-hydroxytryptam
ine-2 (5-HT2) receptor antagonism or regulation of ion channels. A review o
f the pertinent literature on migraine prophylaxis in children is presented
. Dosing guidelines are presented based on the limited data available and c
linical experience.